Transvenous implantation of cardioverter defibrillators in the Electrophysiology Laboratory at CAMC.
Since 1989, 78 patients have had Implantable Cardioverter Defibrillator (ICD) systems implanted in the Electrophysiology Laboratory (EPS) at the Charleston Area Medical Center. Between June 1993 and December 1994, 28 patients (21 males, 7 females) had new transvenous ICD systems successfully implanted in the Electrophysiology Laboratory. Coronary artery disease was present in 22 patients (76%). The mean left ventricular ejection fraction measured 28 percent (range 19%-45%), and the mean follow-up was 159 +/- 112 days (5.3 months). Twelve patients (43%) experienced shock, with an average of three per patient. The implantation of transvenous ICD systems in an electrophysiology laboratory is feasible, efficacious, safe, and associated with rapid patient recovery. With advances in technology, the procedure is becoming more comparable to a pacemaker implantation.
McCowan
R J
RJ
Department of Cardiology, Charleston Area Medical Center, USA.
Slayyeh
Y
Y
Cook
F
F
Johnson
W
W
Allen
S
S
Via
J
J
Workman
K
K
Thorpe
C
C
D002311:Cardiomyopathy, Dilated / Q000628:therapy; D003327:Coronary Disease / Q000628:therapy*; D017147:Defibrillators, Implantable; D004594:Electrophysiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D014903:West Virginia